Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Abstract
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
DOI: https://doi.org/10.15844/pedneurbriefs-25-5-3 | Journal eISSN: 2166-6482
Language: English
Page range: 35 - 36
Published on: May 1, 2011
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2011 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.